Draft Discussion Points and Questions to the Committee

First Page		Document Content
Microbiology Telavancin Methicillin-resistant Staphylococcus aureus Nosocomial infection Hospital-acquired pneumonia Pneumonia Nephrotoxicity Medicine Infectious diseases Health		Draft Discussion Points and Questions to the Committee Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 16,13 KB Share Document on Facebook

	PDF Document DocID: 1xRXL - View Document
	PDF Document DocID: 1xQkg - View Document
	PDF Document DocID: 1xQ5g - View Document
	PDF Document DocID: 1xLM9 - View Document
	PDF Document DocID: 1xKA5 - View Document